Patent details

EP1351706 Title: FACTOR XIII IN COMBINATION WITH FACTOR IX FOR TREATING HEMOPHILIA B

Basic Information

Publication number:
EP1351706
PCT Application Number:
PCT/US/2001/047144
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019934702
PCT Publication Number:
WO/2002/038167
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FACTOR XIII IN COMBINATION WITH FACTOR IX FOR TREATING HEMOPHILIA B
French Title of Invention:
FACTEUR XIII EN COMBINAISON AVEC FACTEUR IX POUR LE TRAITEMENT DE L'HEMOPHILIE B
German Title of Invention:
FAKTOR XIII IN KOMBINATION MIT FAKTOR IX ZUR BEHANDLUNG VON HÄMOPHILIE B
SPC Number:

Dates

Filing date:
08/11/2001
Grant date:
25/07/2007
EP Publication Date:
25/07/2007
PCT Publication Date:
16/05/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/10/2003
EP B1 Publication Date:
25/07/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/11/2007
Expiration date:
08/11/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/11/2001
 
 

Name:
ZymoGenetics Inc.
Address:
1201 Eastlake Avenue East, Seattle, WA 98102, United States (US)

Inventor

1

Name:
ROSE Lynn, M.
Address:
United States (US)

2

Name:
OHRSTROM Jan
Address:
United States (US)

3

Name:
BISHOP Paul, D.
Address:
United States (US)

Priority

Priority Number:
247362 P
Priority Date:
10/11/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/36;
Filing date Document type Number of pages